COVID-19 Susceptibility and Outcomes Among People Living With HIV in San Francisco.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 01 2021
Historique:
pubmed: 13 10 2020
medline: 19 12 2020
entrez: 12 10 2020
Statut: ppublish

Résumé

Studies to examine whether HIV predisposes to a higher incidence of COVID-19 or more severe disease are accumulating. Initial studies from New York City suggested more severe disease among people living with HIV (PLWH), but this was during a time when hospitals were over-capacity and health systems stretched. This report presents the incidence and outcomes among PLWH with COVID-19 in San Francisco over the first 6 months of the pandemic. Community transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first reported in San Francisco on March 5, 2020. This report examines the match of the San Francisco Department of Public Health COVID-19 testing database and the San Francisco Department of Public Health HIV Surveillance case registry from March 24, 2020, to September 3, 2020. Among 4252 COVID-19 tests performed among PLWH, 4.5% (N = 193) were positive for COVID-19, compared with a 3.5% (N = 9626) positivity rate among the 272,555 people without HIV tested for COVID-19 (P < 0.001). The mean age of those infected with HIV/COVID-19 was 48 years (20-76), 38.9% White, 38.3% Latinx, 11.9% Black, and 91.2% were men. Only 54.6% of coinfected PLWH were housed, with the remainder marginally housed. The rate of severe illness with COVID-19 was not increased among PLWH. In San Francisco, susceptibility to COVID-19 was increased among PLWH over the first 6 months of the pandemic, although clinical outcomes were similar to those without HIV. Homelessness and higher rates of congregate living situations among PLWH likely accounted for this disparity. Special efforts to house patients with marginal housing during the COVID-19 pandemic are needed.

Identifiants

pubmed: 33044323
doi: 10.1097/QAI.0000000000002531
pmc: PMC7727319
pii: 00126334-202101010-00003
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-21

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI158013
Pays : United States

Références

San Francisco Department of Public Health. HIV Epidemiology Annual Report 2019. Available at: https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/AnnualReport2019_Indigo_20200914_Web_fixed.pdf . Accessed September 20, 2020.
Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS. 2018;32:277–292.
Triant VA. Cardiovascular disease and HIV infection. Curr HIV/AIDS Rep. 2013;10:199–206.
Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162:335–344.
Elfiky AA. Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci. 2020;253:117592.
Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2020;173:536–541.
PNS. Randomized clinical trial for the prevention of SARS-CoV-2 infection (COVID-19) in healthcare personnel (EPICOS). Available at: https://clinicaltrials.gov/ct2/show/study/NCT04334928 . Accessed April 1, 2020.
San Francisco Department of Public Health. Order of the health officer no. C19-07. Directing all individuals living in the county to shelter at their place of residence. Available at: https://www.sfdph.org/dph/alerts/files/HealthOrderC19-07-%20Shelter-in-Place.pdf . Accessed March 16, 2020.
UNAIDS. Modelling the Extreme—COVID-19 and AIDS-Related Deaths. 2020. Available at: https://www.unaids.org/en/resources/presscentre/featurestories/2020/may/20200525_modelling-the-extreme . Accessed September 20, 2020.
Park LS, Rentsch CT, Sigel K, et al. COVID-19 in the largest US HIV cohort. AIDS 2020: 23rd International AIDS Conference San Francisco/Oakland Virtual; July 6–10, 2020. Abstract LBPEC23.
Boulle A, Davies M, Hussey H, et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. 2020:ciaa1198. doi: 10.1093/cid/ciaa1198. [epub ahead of print].
doi: 10.1093/cid/ciaa1198
Fagan K. None of Homeless Who Tested Positive at Big SF Shelter Showed Serious Coronavirus Symptoms. San Francisco, CA: Chronicle; 2020. Available at: https://www.sfchronicle.com/bayarea/article/None-of-homeless-who-tested-positive-at-big-SF-15206152.php . Accessed April 16, 2020.

Auteurs

Darpun Sachdev (D)

San Francisco Department of Public Health, Population Health Division, Disease Prevention and Control Branch, San Francisco, CA.

Elise Mara (E)

San Francisco Department of Public Health, Population Health Division, Applied Research, Community Health Epidemiology and Surveillance Branch, San Francisco, CA.

Ling Hsu (L)

San Francisco Department of Public Health, Population Health Division, Applied Research, Community Health Epidemiology and Surveillance Branch, San Francisco, CA.

Susan Scheer (S)

San Francisco Department of Public Health, Population Health Division, Applied Research, Community Health Epidemiology and Surveillance Branch, San Francisco, CA.

George Rutherford (G)

Division of Epidemiology and Biostatistics, Department of Medicine, University of California San Francisco, San Francisco, CA; and.

Wayne Enanoria (W)

Division of Epidemiology and Biostatistics, Department of Medicine, University of California San Francisco, San Francisco, CA; and.

Monica Gandhi (M)

Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH